These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 11893834)
1. The domain-specific, stage-limited impact of the apolipoprotein E epsilon-4 allele on cognitive functions in Alzheimer's disease. Kim KW; Jhoo JH; Lee JH; Lee DY; Lee KU; Youn JC; Youn JY; Woo JI Dement Geriatr Cogn Disord; 2002; 13(3):125-9. PubMed ID: 11893834 [TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease. Bizzarro A; Marra C; Acciarri A; Valenza A; Tiziano FD; Brahe C; Masullo C Dement Geriatr Cogn Disord; 2005; 20(4):254-61. PubMed ID: 16103669 [TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia. McGuinness B; Carson R; Barrett SL; Craig D; Passmore AP Neurosci Lett; 2010 Oct; 483(1):62-6. PubMed ID: 20678545 [TBL] [Abstract][Full Text] [Related]
5. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging. Klages JD; Fisk JD; Rockwood K Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072 [TBL] [Abstract][Full Text] [Related]
6. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism. Lehtovirta M; Soininen H; Helisalmi S; Mannermaa A; Helkala EL; Hartikainen P; Hänninen T; Ryynänen M; Riekkinen PJ Neurology; 1996 Feb; 46(2):413-9. PubMed ID: 8614504 [TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients. Marra C; Bizzarro A; Daniele A; De Luca L; Ferraccioli M; Valenza A; Brahe C; Tiziano FD; Gainotti G; Masullo C Dement Geriatr Cogn Disord; 2004; 18(2):125-31. PubMed ID: 15211066 [TBL] [Abstract][Full Text] [Related]
8. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment. Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169 [TBL] [Abstract][Full Text] [Related]
9. Effect of the apolipoprotein E epsilon4 allele on the efficacy and tolerability of galantamine in the treatment of Alzheimer's disease. Suh GH; Jung HY; Lee CU; Oh BH; Lee SK; Lee N; Kim J; Kee BS; Ko D; Kim YH; Ju YS; Hong I; Choi S; Dement Geriatr Cogn Disord; 2006; 21(1):33-9. PubMed ID: 16254428 [TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele. Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251 [TBL] [Abstract][Full Text] [Related]
11. Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E epsilon4 allele. Juottonen K; Lehtovirta M; Helisalmi S; Riekkinen PJ; Soininen H J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):322-7. PubMed ID: 9728943 [TBL] [Abstract][Full Text] [Related]
12. Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease. Monastero R; Mariani E; Camarda C; Ingegni T; Averna MR; Senin U; Camarda R; Mecocci P Acta Psychiatr Scand; 2006 Jan; 113(1):59-63. PubMed ID: 16390371 [TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis. Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282 [TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492 [TBL] [Abstract][Full Text] [Related]
15. Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease. Bondi MW; Salmon DP; Galasko D; Thomas RG; Thal LJ Psychol Aging; 1999 Jun; 14(2):295-303. PubMed ID: 10403716 [TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E ε4 Modulates Cognitive Profiles, Hippocampal Volume, and Resting-State Functional Connectivity in Alzheimer's Disease. Wang X; Wang J; He Y; Li H; Yuan H; Evans A; Yu X; He Y; Wang H J Alzheimers Dis; 2015; 45(3):781-95. PubMed ID: 25624419 [TBL] [Abstract][Full Text] [Related]
17. The effect of the ApoE epsilon4 allele on recognition memory for olfactory and visual stimuli in patients with pathologically confirmed Alzheimer's disease, probable Alzheimer's disease, and healthy elderly controls. Gilbert PE; Murphy C J Clin Exp Neuropsychol; 2004 Sep; 26(6):779-94. PubMed ID: 15370375 [TBL] [Abstract][Full Text] [Related]
18. Impact of APOE status on cognitive maintenance in healthy elderly persons. Zehnder AE; Bläsi S; Berres M; Monsch AU; Stähelin HB; Spiegel R Int J Geriatr Psychiatry; 2009 Feb; 24(2):132-41. PubMed ID: 18615849 [TBL] [Abstract][Full Text] [Related]
19. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele. Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606 [TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging. Hsiung GY; Sadovnick AD; Feldman H CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]